Regina Némethné Csillag

Title: The Innovative Contributions of Regina Némethné Csillag

Introduction

Regina Némethné Csillag is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystals for drug formulation. With a total of 2 patents, her work focuses on addressing critical neurodegenerative and neurodevelopmental diseases.

Latest Patents

Regina's latest patents include innovative formulations of Blarcamesine co-crystals. These formulations are designed for the manufacture of pharmaceutical dosage forms, specifically targeting the treatment of conditions such as Alzheimer's disease, Parkinson's disease dementia, and Rett syndrome. The patents detail the processes for preparing these co-crystals, including the racemic-(±)-blarcamesine hydrochloride and its enantiomers, (S)-(−)-blarcamesine hydrochloride and (R)-(+)-blarcamesine hydrochloride.

Career Highlights

Regina is currently employed at Egis Gyógyszergyár Zrt., a leading pharmaceutical company in Hungary. Her role involves extensive research and development, contributing to the advancement of pharmaceutical technologies. Her innovative spirit and dedication to improving patient outcomes have made her a valuable asset to her team.

Collaborations

Regina collaborates with talented colleagues, including Zsuzsanna Szokol and Tamás Nagy. Together, they work on various projects aimed at enhancing drug formulations and therapeutic methods.

Conclusion

Regina Némethné Csillag's contributions to pharmaceutical innovation are noteworthy. Her patents reflect a commitment to addressing significant health challenges through advanced drug formulations. Her work continues to impact the field positively, paving the way for future advancements in treatment options.